Tento výsledek nelze pro nepřihlášené uživatele zobrazit.
K zobrazení výsledku je třeba se přihlásit.

Emerging racial disparities among Medicare beneficiaries and Veterans with metastatic castration-sensitive prostate cancer.

Autor: George DJ; Department of Medicine, Duke Cancer Institute, Duke University School of Medicine, Durham, NC, USA. Daniel.George@duke.edu., Agarwal N; Department of Internal Medicine, Huntsman Cancer Institute, University of Utah, Salt Lake City, UT, USA., Ramaswamy K; Pfizer Inc., New York, NY, USA., Klaassen Z; Department of Surgery, Medical College of Georgia at Augusta University, Georgia Cancer Center, Augusta, GA, USA., Bitting RL; Department of Medicine, Duke Cancer Institute, Duke University School of Medicine, Durham, NC, USA.; Department of Medicine, Durham VA Medical Center, Durham, NC, USA., Russell D; Pfizer Inc., New York, NY, USA., Sandin R; Pfizer AB, Sollentuna, Sweden., Emir B; Pfizer Inc., New York, NY, USA., Yang H; Analysis Group, Inc., Boston, MA, USA., Song W; Analysis Group, Inc., Boston, MA, USA., Lin Y; Department of Health Policy and Management, Tulane University, New Orleans, LA, USA., Hong A; Pfizer Inc., New York, NY, USA.; Formerly of Astellas Pharma Inc., Northbrook, IL, USA., Gao W; Analysis Group, Inc., Boston, MA, USA., Freedland SJ; Section of Urology, Durham VA Medical Center, Durham, NC, USA.; Department of Urology, Samuel Oschin Comprehensive Cancer Institute, Cedars-Sinai Medical Center, Los Angeles, CA, USA.

Publikováno v: Prostate cancer and prostatic diseases [Prostate Cancer Prostatic Dis] 2024 Dec; Vol. 27 (4), pp. 765-775. Date of Electronic Publication: 2024 Apr 02.

Intensifying Salvage Therapy in Prostate-specific Antigen Recurrent Prostate Cancer After Radical Prostatectomy with Apalutamide, Salvage Radiation, and Docetaxel: The Phase 2 STARTAR Trial.

Autor: Zhang T; Duke Cancer Institute Center for Prostate and Urologic Cancers, Duke University, Durham, NC, USA; Division of Hematology and Oncology, Department of Internal Medicine, Simmons Comprehensive Cancer Center, UT Southwestern Medical Center, Dallas, TX, USA., Howard L; Duke Cancer Institute Center for Prostate and Urologic Cancers, Duke University, Durham, NC, USA., Koontz BF; Brody School of Medicine, East Carolina University, Greenville, NC, USA., Tagawa ST; Department of Internal Medicine, Meyer Cancer Center, Weill Cornell Medicine, New York, NY, USA., Nagar H; Department of Internal Medicine, Meyer Cancer Center, Weill Cornell Medicine, New York, NY, USA; Department of Radiation Oncology, Meyer Cancer Center, Weill Cornell Medicine, New York, NY, USA., Bitting RL; Duke Cancer Institute Center for Prostate and Urologic Cancers, Duke University, Durham, NC, USA; Wake Forest Baptist Medical Center, Winston-Salem, NC, USA., Frizzell BA; Wake Forest Baptist Medical Center, Winston-Salem, NC, USA., Nordquist L; XCancer, Omaha, NE, USA., Rasmussen J; Duke Cancer Institute Center for Prostate and Urologic Cancers, Duke University, Durham, NC, USA., Riggan C; Duke Cancer Institute Center for Prostate and Urologic Cancers, Duke University, Durham, NC, USA., Reyes M; Duke Cancer Institute Center for Prostate and Urologic Cancers, Duke University, Durham, NC, USA., Davies C; Duke Cancer Institute Center for Prostate and Urologic Cancers, Duke University, Durham, NC, USA., Gray SR; Duke Cancer Institute Center for Prostate and Urologic Cancers, Duke University, Durham, NC, USA., Newman CR; Duke Cancer Institute Center for Prostate and Urologic Cancers, Duke University, Durham, NC, USA., Fernandez E; Department of Internal Medicine, Meyer Cancer Center, Weill Cornell Medicine, New York, NY, USA., Ramalingam S; Duke Cancer Institute Center for Prostate and Urologic Cancers, Duke University, Durham, NC, USA., Harrison MR; Duke Cancer Institute Center for Prostate and Urologic Cancers, Duke University, Durham, NC, USA., George DJ; Duke Cancer Institute Center for Prostate and Urologic Cancers, Duke University, Durham, NC, USA., Wu Y; Duke Cancer Institute Center for Prostate and Urologic Cancers, Duke University, Durham, NC, USA., Armstrong AJ; Duke Cancer Institute Center for Prostate and Urologic Cancers, Duke University, Durham, NC, USA. Electronic address: andrew.armstrong@duke.edu.

Publikováno v: European urology oncology [Eur Urol Oncol] 2024 Jul 05. Date of Electronic Publication: 2024 Jul 05.

Marital Status, Living Arrangement, and Survival among Individuals with Advanced Prostate Cancer in the International Registry for Men with Advanced Prostate Cancer.

Autor: Chen N; Department of Epidemiology, Harvard T. H. Chan School of Public Health, Boston, Massachusetts., McGrath CB; Department of Epidemiology, Harvard T. H. Chan School of Public Health, Boston, Massachusetts., Ericsson CI; Department of Epidemiology, Harvard T. H. Chan School of Public Health, Boston, Massachusetts., Vaselkiv JB; Department of Epidemiology, Harvard T. H. Chan School of Public Health, Boston, Massachusetts., Rencsok EM; Department of Epidemiology, Harvard T. H. Chan School of Public Health, Boston, Massachusetts.; Harvard-MIT Division of Health Sciences and Technology, Harvard Medical School, Boston, Massachusetts., Stopsack KH; Department of Epidemiology, Harvard T. H. Chan School of Public Health, Boston, Massachusetts.; Clinical and Translational Epidemiology Unit, Massachusetts General Hospital and Harvard Medical School, Boston, Massachusetts., Guard HE; Department of Epidemiology, Harvard T. H. Chan School of Public Health, Boston, Massachusetts., Autio KA; Department of Medicine, Memorial Sloan Kettering Cancer Center, New York, New York., Rathkopf DE; Department of Medicine, Memorial Sloan Kettering Cancer Center, New York, New York., Enting D; Guy's and St. Thomas' NHS Foundation Trust, London, United Kingdom., Bitting RL; Durham VA Health Care System, Durham, North Carolina., Mateo J; Vall d'Hebron Institute of Oncology (VHIO), Vall d'Hebron University Hospital Campus, Barcelona, Spain., Githiaka CW; Department of Surgery, University of Nairobi, Nairobi, Kenya., Chi KN; BC Cancer, Vancouver, British Columbia, Canada., Cheng HH; University of Washington and Fred Hutchinson Cancer Center, Seattle, Washington., Davis ID; Monash University Faculty of Medicine, Melbourne, Australia.; Eastern Health, Melbourne, Australia., Anderson SG; The Glasgow-Caribbean Centre for Development Research and the Caribbean Institute of Health Research, The University of the West Indies, Bridgetown, Barbados.; African-Caribbean Cancer Consortium, Philadelphia, Pennsylvania., Badal SAM; African-Caribbean Cancer Consortium, Philadelphia, Pennsylvania.; The University of the West Indies Mona, Kingston, Jamaica., Bjartell A; Department of Urology, Skåne University Hospital, Malmö, Sweden., Russnes KM; Department of Oncology, Oslo University Hospital, Oslo, Norway., Heath EI; Barbara Ann Karmanos Cancer Institute, Wayne State University, Detroit, Michigan., Pomerantz MM; Department of Medical Oncology, Dana-Farber Cancer Institute, Boston, Massachusetts., Henegan JC; Department of Medicine, University of Mississippi Medical Center, Jackson, Mississippi., Hyslop T; Sidney Kimmel Cancer Center, Thomas Jefferson University, Philadelphia, Pennsylvania., Esteban E; Department of Medical Oncology, Hospital Universitario Central of Asturias, ISPA, Oviedo, Spain., Omlin A; OnkoZentrum, Zurich, Switzerland., McDermott R; St Vincent's University Hospital and Cancer Trials Ireland, Dublin, Ireland., Fay AP; PUCRS School of Medicine, Hospital Nora Teixeira, Porto Alegre, Brazil., Popoola AA; University of Ilorin, Ilorin, Nigeria., Ragin C; African-Caribbean Cancer Consortium, Philadelphia, Pennsylvania.; Fox Chase Cancer Center, Philadelphia, Pennsylvania., Nowak J; Cancer ABCs, Brooklyn, New York., Gerke T; Prostate Cancer Clinical Trials Consortium, New York, New York., Kantoff PW; Department of Medicine, Memorial Sloan Kettering Cancer Center, New York, New York., George DJ; Durham VA Health Care System, Durham, North Carolina., Penney KL; Department of Epidemiology, Harvard T. H. Chan School of Public Health, Boston, Massachusetts.; Channing Division of Network Medicine, Brigham and Women's Hospital and Harvard Medical School, Boston, Massachusetts., Mucci LA; Department of Epidemiology, Harvard T. H. Chan School of Public Health, Boston, Massachusetts.

Publikováno v: Cancer epidemiology, biomarkers & prevention : a publication of the American Association for Cancer Research, cosponsored by the American Society of Preventive Oncology [Cancer Epidemiol Biomarkers Prev] 2024 Mar 01; Vol. 33 (3), pp. 419-425.

Genomic classifiers and prognosis of localized prostate cancer: a systematic review.

Autor: Boyer MJ; Durham VA Health Care System, Durham, NC, USA. matthew.boyer@duke.edu.; Department of Radiation Oncology, Duke University School of Medicine, Durham, NC, USA. matthew.boyer@duke.edu., Carpenter DJ; Wellstar Radiation Oncology, Hiram, GA, USA., Gingrich JR; Durham VA Health Care System, Durham, NC, USA.; Department of Urology, Duke University School of Medicine, Durham, NC, USA., Raman SR; Department of Population Health Sciences, Duke University School of Medicine, Durham, NC, USA., Sirohi D; Department of Pathology, University of Utah School of Medicine, Salt Lake City, UT, USA., Tabriz AA; Department of Health Outcomes and Behavior, Moffitt Cancer Center, Tampa, FL, USA., Rompre-Broduer A; Division of Urology, McGill University, Montreal, QC, Canada., Lunyera J; Division of General Internal Medicine, Department of Medicine, Duke University School of Medicine, Durham, NC, USA., Basher F; Division of Medical Oncology, Department of Medicine, Duke University School of Medicine, Durham, NC, USA., Bitting RL; Durham VA Health Care System, Durham, NC, USA.; Division of Medical Oncology, Department of Medicine, Duke University School of Medicine, Durham, NC, USA., Kosinski A; Department of Biostatistics & Bioinformatics, Duke University School of Medicine, Durham, NC, USA., Cantrell S; Duke University Medical Center Library & Archives, Duke University School of Medicine, Durham, NC, USA., Gordon AM; Durham VA Health Care System, Durham, NC, USA., Ear B; Durham VA Health Care System, Durham, NC, USA., Gierisch JM; Durham VA Health Care System, Durham, NC, USA.; Division of General Internal Medicine, Department of Medicine, Duke University School of Medicine, Durham, NC, USA.; Department of Population Health, Duke University School of Medicine, Durham, NC, USA., Jacobs M; Durham VA Health Care System, Durham, NC, USA., Goldstein KM; Durham VA Health Care System, Durham, NC, USA.; Division of General Internal Medicine, Department of Medicine, Duke University School of Medicine, Durham, NC, USA.

Publikováno v: Prostate cancer and prostatic diseases [Prostate Cancer Prostatic Dis] 2024 Jan 10. Date of Electronic Publication: 2024 Jan 10.